| scholarly article | Q13442814 |
| P2093 | author name string | J. J. Mekalanos | |
| M. J. Mahan | |||
| M. R. Neutra | |||
| P. Michetti | |||
| J. M. Slauch | |||
| P2860 | cites work | The structure and function of human IgA | Q24307588 |
| A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. | Q34286908 | ||
| Intestinal Colonization and Virulence of Salmonella in Mice | Q34462691 | ||
| Lymphoepithelial interactions in the mucosal immune system | Q34531045 | ||
| Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium | Q35972318 | ||
| Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages | Q36162205 | ||
| Penetration of Salmonella through a polarized Madin-Darby canine kidney epithelial cell monolayer | Q36219136 | ||
| Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins | Q36220664 | ||
| The route of enteric infection in normal mice | Q36273394 | ||
| Summary of an international workshop on typhoid fever | Q36476621 | ||
| Systemic and intestinal immunities after natural typhoid infection | Q37214474 | ||
| ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae | Q37412008 | ||
| Future vaccines against enteric pathogens | Q37873313 | ||
| Molecular mechanisms of immunoglobulin A defense | Q38236161 | ||
| Overview of the mucosal immune system | Q38642485 | ||
| Immunobiology of IgA. | Q39539523 | ||
| New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection | Q40152851 | ||
| Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay | Q40849304 | ||
| Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study | Q42522319 | ||
| Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi | Q50203256 | ||
| Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies | Q50204703 | ||
| Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine | Q50206206 | ||
| Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice | Q50212092 | ||
| Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation | Q69382046 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| Fc receptor | Q417823 | ||
| invasive pathogen | Q122160590 | ||
| P304 | page(s) | 1786-1792 | |
| P577 | publication date | 1992-05-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium | |
| P478 | volume | 60 |
| Q35098202 | A Cronobacter turicensis O1 antigen-specific monoclonal antibody inhibits bacterial motility and entry into epithelial cells |
| Q34003951 | A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation |
| Q33557719 | A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin |
| Q25257734 | A novel surface protein of Trichomonas vaginalis is regulated independently by low iron and contact with vaginal epithelial cells |
| Q42441197 | Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response |
| Q35383416 | Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen |
| Q43080002 | Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri |
| Q40269904 | Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. |
| Q33962800 | Antibodies in milk |
| Q33598405 | Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk |
| Q32077043 | Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. |
| Q36156058 | Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. |
| Q41110063 | Cellular Processing Limits the Heterologous Expression of Secretory Component in Mammalian Cells |
| Q34000952 | Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein |
| Q34144392 | Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. |
| Q35426022 | Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies |
| Q36950045 | Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity |
| Q33595830 | Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage |
| Q34357220 | Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization |
| Q90194902 | Development of Salmonellosis as Affected by Bioactive Food Compounds |
| Q33579987 | Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa |
| Q42679183 | Different mutations in the oafA gene lead to loss of O5-antigen expression in Salmonella enterica serovar Typhimurium |
| Q36646721 | Exposure of Salmonella enterica Serovar typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclase-dependent pathway |
| Q41959778 | Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology |
| Q34120273 | Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination |
| Q93042571 | Functional characterization of a broad and potent neutralizing monoclonal antibody directed against outer membrane protein (OMP) of Salmonella typhimurium |
| Q38765335 | Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut. |
| Q36184367 | Glycoconjugate vaccine strategies for protection against invasive Salmonella infections |
| Q40253058 | High-avidity IgA protects the intestine by enchaining growing bacteria |
| Q34002939 | Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens |
| Q34004684 | Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate |
| Q36389762 | Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes |
| Q35385770 | Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague |
| Q35064867 | In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells |
| Q35216497 | Independent bottlenecks characterize colonization of systemic compartments and gut lymphoid tissue by salmonella |
| Q37248099 | Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein. |
| Q34985195 | Ingested allergens must be absorbed systemically to induce systemic anaphylaxis |
| Q39961574 | Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. |
| Q90591990 | Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies |
| Q37280601 | Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens |
| Q37219548 | Intermittent fasting favored the resolution of Salmonella typhimurium infection in middle-aged BALB/c mice |
| Q35080048 | Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis |
| Q35498094 | Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection |
| Q89983803 | LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus |
| Q39654238 | Lipopolysaccharide-specific but not anti-flagellar immunoglobulin A monoclonal antibodies prevent Salmonella enterica serotype enteritidis invasion and replication within HEp-2 cell monolayers |
| Q35210799 | M Cell-Mediated Antigen Transport and Monoclonal IgA Antibodies for Mucosal Immune Protection |
| Q35348835 | Microbiology of bacterial translocation in humans |
| Q36940409 | Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium |
| Q39843074 | Molecular characterization of the oafA locus responsible for acetylation of Salmonella typhimurium O-antigen: oafA is a member of a family of integral membrane trans-acylases |
| Q35598208 | Molecular cloning, mapping, and regulation of Pho regulon genes for phosphonate breakdown by the phosphonatase pathway of Salmonella typhimurium LT2 |
| Q33617401 | Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro |
| Q36365336 | Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis |
| Q35469834 | Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria |
| Q94921992 | More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis |
| Q37880344 | Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge |
| Q35210838 | Mucosal Immunity to Vaccines: Current Concepts for Vaccine Development and Immune Response Analysis |
| Q37427432 | Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. |
| Q34083154 | Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization |
| Q35838661 | Mucosal immunity: overcoming the barrier for induction of proximal responses. |
| Q38123163 | Multi-faceted functions of secretory IgA at mucosal surfaces |
| Q34002438 | Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines. |
| Q34521851 | Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. |
| Q34009973 | Oral microbial ecology and the role of salivary immunoglobulin A |
| Q37307095 | Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge |
| Q34257517 | Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice |
| Q39831824 | Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets. |
| Q35117688 | Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice |
| Q35941385 | Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. |
| Q55364566 | Persistent Salmonella enterica serovar Typhimurium Infection Increases the Susceptibility of Mice to Develop Intestinal Inflammation. |
| Q40050124 | Plasma-Derived Polyreactive Secretory-Like IgA and IgM Opsonizing Salmonella enterica Typhimurium Reduces Invasion and Gut Tissue Inflammation through Agglutination |
| Q83498386 | Production of immunoglobulin A in different reactor configurations |
| Q37405767 | Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants. |
| Q35454882 | Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection |
| Q30628895 | Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology |
| Q34948157 | Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates |
| Q40114957 | Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection |
| Q28354066 | Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium |
| Q33848974 | Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches |
| Q33763109 | Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection |
| Q35519116 | Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization |
| Q33828828 | Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid |
| Q24620817 | Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut |
| Q37175693 | Secretory IgA: arresting microbial pathogens at epithelial borders |
| Q36942577 | Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches |
| Q35960709 | Specific Monoclonal Antibody Overcomes the Salmonella enterica Serovar Typhimurium's Adaptive Mechanisms of Intramacrophage Survival and Replication |
| Q33347255 | Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces |
| Q33769451 | Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination |
| Q21558386 | Stress modulates intestinal secretory immunoglobulin A. |
| Q35549256 | Synergistic effect of mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid. |
| Q27010010 | The Dynamic Interactions between Salmonella and the Microbiota, within the Challenging Niche of the Gastrointestinal Tract |
| Q41465504 | The immunopathology of M cells |
| Q34876531 | The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific |
| Q37778734 | The role of secretory antibodies in infection immunity |
| Q41475755 | Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice |
| Q35401490 | Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice |
| Q35824212 | Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid |
| Q39373957 | Vaccination against Salmonella Infection: the Mucosal Way. |
| Q33975703 | Vaccination strategies for mucosal immune responses |
| Q34554763 | Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA. |
| Q48321872 | Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination |
Search more.